Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Treasury Shares (2017 - 2025)

Palisade Bio has reported Treasury Shares over the past 10 years, most recently at $24.8 million for Q4 2025.

  • Quarterly Treasury Shares changed N/A to $24.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $24.8 million through Dec 2025, changed N/A year-over-year, with the annual reading at $24.8 million for FY2025, N/A changed from the prior year.
  • Treasury Shares was $24.8 million for Q4 2025 at Palisade Bio, up from $24195.0 in the prior quarter.
  • Over five years, Treasury Shares peaked at $24.8 million in Q4 2025 and troughed at $8817.0 in Q2 2021.
  • The 3-year median for Treasury Shares is $141857.0 (2023), against an average of $4.3 million.